Coal Stocks; Lucky Strike (TSX-V:LKY) Nkak Coal Project Acquisition and Coal Transportation Service Agreement
VANCOUVER, BRITISH COLUMBIA, CANADA - April 27, 2011 (Investorideas.com Mining Newswire) - Cathy Fong, CEO of Lucky Strike Resources Ltd. (TSX-V:LKY) (the "Company" or "Lucky Strike"),is pleased to report the Company signed a letter agreement (the "Letter Agreement") with a private Mongolian company (the "Representative") that represents the owner of two exploration licences covering an area of 8,736 hectares within the eastern boundary 3 km west of the Olonbulag coking coal deposits in the aimag of Hovd in southwest Mongolia and known as the Nariin Khargait and Ar Khadnii Ovoo ("NKAK") coal properties (the "Properties"). The Representative has also confirmed that it can secure transportation contracts for the transportation of at least one million tonnes of coal per year from Mongolia to the China border within t! he first three years of operation which will be conducted through a joint venture company (the "JV Company"). It is contemplated by the Letter Agreement that the Properties will be transferred to the JV Company and all transportation licences and contracts will be vested in the JV Company. Pursuant to the terms of the Letter Agreement, the Representative has granted to Lucky Strike an option to acquire up to a 75% interest in the JV Company on the financial terms described below.
NKAK Coal Properties
The NKAK coal properties are located in southwest Mongolia , about 20 km north of the Baitag Chinese border, 500 km southwest of the City of Altai and 1,500 km west of the Capital City of Ulaanbaatar in Mongolia . According to the Representative, the history of the property dates back to 1955 with geological mapping at 1:200,000 scale by a Russian geologic team and further assessment work completed in 1975. The exploration licenses cover areas that include occurrences of Lower Carboniferous Olonbulag terrigenous sediments that host coal seams.
The NKAK properties cover an area of 8,736 hectares and are situated 3 km west of the Olonbulag coal deposits. The Olonbulag coal units include the Nariin Khargait, Buduun Khargait, and Ochiriin Bulag deposits, and are directly southeast of the NKAK properties. They are reported to contain coal seams ranging up to 45m thick. The Representative completed a reconnaissance survey in July 2010 that resulted in the delineation of coal occurrences extending for 11 km in length and 2.5 km in width. In 2010, channel sampling in the prospect area revealed a 10-50m thick coal-rich bed consisting of two seams that crop out along the hinge of an anticline fold.
There is one coal mine 10km from the NKAK properties within Mongolia . There are three coal mines including Wotouquan, Balikun East and Sandaoling just south of the Chinese border in the Xinjiang province of China .
Coal Transportation
Pursuant to the Letter Agreement, the Representative has agreed to use its commercial efforts to secure and assign transportation contracts to the JV Company for the transportation of a minimum of one million tonnes of coal per annum ("tpy") from Mongolia to China within the first three years of operation. The Representative"s affiliate company holds a transportation licence and contract and is currently transporting 500,000 tpy coking coal from Tavan Tolgoi to Tsagaan Had a reloading station through to Gashuun Suhait Mongolian-Chinese border to the final destination of Gants Mod in China . The Representative has advised Lucky Strike that they are in negotiations with numerous additional transportation contracts throughout Mongolia . Tavan Tolgoi is reportedly, the world"s largest coal deposit with an estimated 6.42 billion tonnes of coal reserve and a target production of 15 million tonnes by 2015 according to the Mineral Resources and Petroleum Authority of Mongolia ! and the Golomt Bank"s Mining Department.
Lucky Strike, with the Representative, plans to develop additional transportation logistics operations including fleets of trucks, truck shop, station facilities, warehouse and office for the coal transportation of numerous deposits across Mongolia . The number of tonnes for transportation may be increased, based on investment interest from the capital market.
Mongolia exported 9 million tons of coal in 2010 according to Mongolian Golomt Bank"s Mining Department with a forecast of 16 million tons in 2011 and to reach 45 million tons by 2016. Mongolia"s number one trading partner, China , is estimated to currently receive two-thirds of all Mongolia"s exports.
Financial Terms
In order to acquire up to a 75% ownership interest in the JV Company, Lucky Strike is required to: (a) make a non-refundable payment of US $300,000 to the Representative upon execution of the Letter of Agreement; (b) make US $600,000 in cash payments to the Representative over a three year period of which US$500,000 is payable upon receipt of TSXV approval, US$50,000 is payable on the first year anniversary of the approval date and US $25,000 is payable on both the second and third anniversary of the approval date; and (c) complete a minimum of US$8 million in exploration and development expenditures over a three year period of which US$1 million must be expended by the first year anniversary of the approval date, US$2 million must be expended by the second year anniversary of the approval date and US$5 million must be spent by the third year anniversary of the approval date. The acquisition is subject to completion of legal and technical due diligence and acceptance of the ! TSX Venture Exchange.
Finder's fees may be paid, and will be in accordance with TSX Venture Exchange policies, and is subject to the approval of the regulatory authorities.
Property Review
Edwin Ullmer, P. Geo., a Qualified Person as defined by National Instruments 43-101, has read and approved the technical information in this news release.
On behalf of Management
Lucky Strike Resources Ltd.
"Cathy Fong"
Cathy Fong, Chairman & CEO, Director
Further Information
For further information relating to the Company or this release please visit the Lucky Strike Resource website at www.luckstrikeresources or contact Investor Relations at 604-360-8199 www.luckystrikeresources.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release may contain certain "Forward-Looking Statements" within the meaning of Section 21E of the United States Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, included herein are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time with the Toronto Venture Exchange, the British Columbia Securities Commission and the US Securities and Exchange C! ommission.
The above forward-looking statements reflect management"s current views and are based on certain expectations, estimates and assumptions, which may prove to be incorrect. A number of risks and uncertainties could cause our actual results to differ materially from those expressed or implied by the forward-looking statements, including: (1) the risk that the Company does not execute its business plan, (2) inability to finance operations and growth, (3) inability to obtain all necessary environmental and regulatory approvals, and (4) other factors beyond the Company"s control. These forward-looking statements are made as of the date of this news release and the Company assumes no obligation to update these forward-looking statements, or to update the reasons why actual results differed from those projected in the forward-looking statements.
Wednesday, April 27, 2011
Pharma News; BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) To Present at the Deutsche Bank Annual Health Care Conference
LINCOLNSHIRE, Ill. - April 27, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) will present at the 36th Annual Deutsche Bank Health Care Conference to be held at the InterContinental Hotel, Boston from May 2-4, 2011.
Phillip B. Donenberg, BioSante's senior vice president, finance & CFO, will speak on Tuesday May 3, 2011 at 4:10 pm EDT. He will provide an overview of the company, as well as an update on the LibiGel� (testosterone gel) Phase III clinical development program.
About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other products in development are Bio-T-Gel™, a testosterone gel for male hypogonadism licensed to Teva Pharmaceuticals and an oral contraceptive in Phase II clinical development using BioSante patented technology. The company also is seeking opportunities for its other technologies. Additional information is available online at: www.biosantepharma.com.
Forward-Looking Statements
To the extent any statements made in this news release deal with information that is not historical, these are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about BioSante's plans, objectives, expectations and intentions with respect to future operations and products, the timing of anticipated regulatory submissions and other statements identified by words such as "will," "potential," "could," "can," "believe," "intends," "continue," "plans," "expects," "anticipates," "estimates," "may," other words of similar meaning or the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante's actual results to be materially different than those expressed in or implied by BioSante's forward-looking statements. For BioSante, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing success of BioSante's licensees or sublicensees; the success of clinical testing; and BioSante's need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect BioSante's actual results are described in BioSante's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. All forward-looking statements in this news release speak only as of the date of this news release. BioSante undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Contact:
BioSante Pharmaceuticals
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
or
For Media:
McKinney/Chicago
Alan Zachary
(312) 944-6784 ext. 316
azachary@mckinneychicago.com
Disclosure, Disclaimer/ BPAX is a paid advertising client on Investorideas.com (1000 per month).
LINCOLNSHIRE, Ill. - April 27, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) will present at the 36th Annual Deutsche Bank Health Care Conference to be held at the InterContinental Hotel, Boston from May 2-4, 2011.
Phillip B. Donenberg, BioSante's senior vice president, finance & CFO, will speak on Tuesday May 3, 2011 at 4:10 pm EDT. He will provide an overview of the company, as well as an update on the LibiGel� (testosterone gel) Phase III clinical development program.
About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other products in development are Bio-T-Gel™, a testosterone gel for male hypogonadism licensed to Teva Pharmaceuticals and an oral contraceptive in Phase II clinical development using BioSante patented technology. The company also is seeking opportunities for its other technologies. Additional information is available online at: www.biosantepharma.com.
Forward-Looking Statements
To the extent any statements made in this news release deal with information that is not historical, these are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about BioSante's plans, objectives, expectations and intentions with respect to future operations and products, the timing of anticipated regulatory submissions and other statements identified by words such as "will," "potential," "could," "can," "believe," "intends," "continue," "plans," "expects," "anticipates," "estimates," "may," other words of similar meaning or the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante's actual results to be materially different than those expressed in or implied by BioSante's forward-looking statements. For BioSante, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing success of BioSante's licensees or sublicensees; the success of clinical testing; and BioSante's need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect BioSante's actual results are described in BioSante's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. All forward-looking statements in this news release speak only as of the date of this news release. BioSante undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Contact:
BioSante Pharmaceuticals
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
or
For Media:
McKinney/Chicago
Alan Zachary
(312) 944-6784 ext. 316
azachary@mckinneychicago.com
Disclosure, Disclaimer/ BPAX is a paid advertising client on Investorideas.com (1000 per month).
Tuesday, April 26, 2011
Mining Stocks; LOMIKO Metals (TSX-V:LMR; OTC:LMRMF) signs Definitive Agreement for $5 Million Equity Line Financing
Vancouver, BC - April 26, 2011 (Investorideas.com mining stocks newswire) � LOMIKO METALS INC. (TSX-V:LMR, OTC: LMRMF, Europe: ISIN: CA54163Q1028, WKN: A0Q9W7,) ("Lomiko" or "the Company") is pleased to announce that it has entered into an Equity Line Facility Agreement ("ELF") with Dutchess Opportunity Cayman Fund Ltd., a fund managed by Dutchess Capital Management, II LLC ("Dutchess"). Under the terms of the ELF, Dutchess has conditionally committed to provide up to $5 million of capital during a 36�month period, at Lomiko�s discretion, through the issue of common shares.
The ELF remains subject to certain conditions precedent, including the approval of the TSX Venture Exchange, a preliminary short form base shelf prospectus and a prospectus supplement in certain jurisdictions in Canada, which will be subject to the required corporate and regulatory approvals. The Company has received the necessary exemptive relief orders from the applicable securities regulatory authorities and has filed a voluntary Annual Information Form.
Subject to receipt of all necessary approvals and filing, Lomiko can draw on Dutchess' commitment by sending draw down notices based on the company's requirements. Each draw down will be priced based on the then�current stock price in accordance with an agreed�upon formula. Lomiko will control the timing and amount of any share sales to Dutchess. The Company is restricted from issuing shares under a draw down to the extent such shares would result in Dutchess and its affiliates owning more than 10% of the issued and outstanding shares of the Company.
The agreement can be terminated at any time by the Company without the payment of any additional fees. No commissions will be paid by Lomiko as a result of the signing of the ELF.
"This significant financing arrangement gives Lomiko the ability to compete for larger projects and access capital for development of those projects quickly after any discovery" commented A. Paul Gill, Chief Executive Officer. "The ELF is a well�designed tool for growth oriented companies with liquidity."
Dutchess Capital is an investment manager which provides creative financing for public companies, Founded in 2000, for almost a decade, Dutchess has been a global leader in Equity Line Facilities (ELFs) and has transacted in excess of $1.8 billion in such financings worldwide. The ELF is a flexible financing structure by which publicly traded companies can raise capital quickly, efficiently and with less dilution than most traditional offerings. For more information, please visit www.dutchesscapital.com or contact Jessica Geran, Director of Corporate Finance at 617�301�4703.
For more information, please contact Paul Gill at 604�729�5312 Email: lomiko@dccnet.com. Website: www.lomiko.com.
On behalf of Lomiko Metals Inc,
Signed: "A. Paul Gill"
A. Paul Gill, President & CEO
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This release has been prepared by management and no regulatory authority has approved or disapproved the information contained herein.
Vancouver, BC - April 26, 2011 (Investorideas.com mining stocks newswire) � LOMIKO METALS INC. (TSX-V:LMR, OTC: LMRMF, Europe: ISIN: CA54163Q1028, WKN: A0Q9W7,) ("Lomiko" or "the Company") is pleased to announce that it has entered into an Equity Line Facility Agreement ("ELF") with Dutchess Opportunity Cayman Fund Ltd., a fund managed by Dutchess Capital Management, II LLC ("Dutchess"). Under the terms of the ELF, Dutchess has conditionally committed to provide up to $5 million of capital during a 36�month period, at Lomiko�s discretion, through the issue of common shares.
The ELF remains subject to certain conditions precedent, including the approval of the TSX Venture Exchange, a preliminary short form base shelf prospectus and a prospectus supplement in certain jurisdictions in Canada, which will be subject to the required corporate and regulatory approvals. The Company has received the necessary exemptive relief orders from the applicable securities regulatory authorities and has filed a voluntary Annual Information Form.
Subject to receipt of all necessary approvals and filing, Lomiko can draw on Dutchess' commitment by sending draw down notices based on the company's requirements. Each draw down will be priced based on the then�current stock price in accordance with an agreed�upon formula. Lomiko will control the timing and amount of any share sales to Dutchess. The Company is restricted from issuing shares under a draw down to the extent such shares would result in Dutchess and its affiliates owning more than 10% of the issued and outstanding shares of the Company.
The agreement can be terminated at any time by the Company without the payment of any additional fees. No commissions will be paid by Lomiko as a result of the signing of the ELF.
"This significant financing arrangement gives Lomiko the ability to compete for larger projects and access capital for development of those projects quickly after any discovery" commented A. Paul Gill, Chief Executive Officer. "The ELF is a well�designed tool for growth oriented companies with liquidity."
Dutchess Capital is an investment manager which provides creative financing for public companies, Founded in 2000, for almost a decade, Dutchess has been a global leader in Equity Line Facilities (ELFs) and has transacted in excess of $1.8 billion in such financings worldwide. The ELF is a flexible financing structure by which publicly traded companies can raise capital quickly, efficiently and with less dilution than most traditional offerings. For more information, please visit www.dutchesscapital.com or contact Jessica Geran, Director of Corporate Finance at 617�301�4703.
For more information, please contact Paul Gill at 604�729�5312 Email: lomiko@dccnet.com. Website: www.lomiko.com.
On behalf of Lomiko Metals Inc,
Signed: "A. Paul Gill"
A. Paul Gill, President & CEO
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This release has been prepared by management and no regulatory authority has approved or disapproved the information contained herein.
Disclaimer/ Disclosure: The following news is paid for and /or published as information only for our readers. Lomiko Metals Inc. (TSX-V: LMR) three month showcase gold stock on Investorideas.com and all related mining portals and blogs (one thousand per month)
Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of principal .This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of principal .This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Security Stocks; Visualant (OTCBB:VSUL) Subsidiary, TransTech Systems, Releases New TransCam™ Identification Card Photo Capture Solutions for Government and Commercial Use
SEATTLE - April 26, 2011 (Investorideas.com Defense Newswire) - Visualant, Inc. (OTCBB: VSUL), a pioneer provider of industry-leading color based identification and diagnostic solutions, an emerging leader in security and authentication systems technology and distributor of a wide variety of security solutions through its wholly-owned subsidiary, TransTech Systems, Inc., is pleased to announce that TransTech Systems has released a new line of TransCam™ photo identification solutions tailored to the particular needs of the identification and security market.
The ID security and access control industries have unique requirements for image capture systems. Cameras must be high-quality and low-cost, produce quality images in all lighting conditions, and able to interface with specialized badge design software for instant creation and issuance of identification credentials. These systems must also be designed for portable use in multiple locations such as a school district, and for permanent installation at a central location, such as a corporate security office. TransTech Systems has recognized these needs and designed two unique camera kits under the TransCam™ brand name. These two unique camera kits are available for immediate distribution.
The TransCam WDM camera kit is designed for portability and includes both a top-of-the-line 8 megapixel high-definition compact camera for capturing crisp and vibrant images of the subject, and TWAIN-driver software solution. The camera can be controlled directly from the user's computer to capture the perfect photo, and the integrated face-finder combined with auto-crop ensures that ID badges are created quickly and professionally.
The TransCam ACK camera kit is designed for high-volume badge issuance. This kit combines a versatile camera from a leading camera manufacturer with a unique TWAIN-driver software solution that provides the user direct control of camera features such as zoom and focus without leaving the workstation to make adjustments.
The TransCam™ camera kits are compatible with the most popular ID Badging solutions in the industry. Deluxe versions of the TransCam kits are also available, offering a high-quality blue/gray reversible backdrop and full-size tripod for use with the camera's integrated tripod mount.
About Visualant, Inc.
Visualant, Inc. (OTCBB: VSUL) develops low-cost, high speed, light-based security and quality control solutions for use in homeland security, anti-counterfeiting, forgery/fraud prevention, brand protection and process control applications. Our patent-pending technology uses controlled illumination with specific bands of light, to establish a unique spectral signature for both individual and classes of items. When matched against existing databases, these spectral signatures allow precise identification and authentication of any item or substance. This breakthrough optical sensing and data capture technology is called Spectral Pattern Matching ("SPM"). SPM technology can be miniaturized and is easily integrated into a variety of hand-held or fixed mount configurations, and can be combined in the same package as a bar-code or biometric scanner.
Through its wholly owned subsidiary, TransTech Systems, Inc., the Company provides security and authentication solutions to security and law enforcement markets throughout the United States.
Contact:
Visualant, Inc.:
Lynn Felsinger
206 903 1351
Lynn@visualant.net
Investor Relations
Paul DeRiso
Core Consulting Group
925-465-6088
paul@coreconsultingroup.com
Visualant, Inc. (OTCBB:VSUL) Featured showcase company on Investorideas.com and related security portals and blogs
Visit the showcase page: http://www.investorideas.com/CO/VSUL/
Disclosure and Disclaimer: Visualant, Inc. (OTCBB:VSUL) is a paid advertising featured showcase company on Investorideas.com and related security portals and blogs.
(1500 per month and $five thousand per month in restricted 144 shares)
SEATTLE - April 26, 2011 (Investorideas.com Defense Newswire) - Visualant, Inc. (OTCBB: VSUL), a pioneer provider of industry-leading color based identification and diagnostic solutions, an emerging leader in security and authentication systems technology and distributor of a wide variety of security solutions through its wholly-owned subsidiary, TransTech Systems, Inc., is pleased to announce that TransTech Systems has released a new line of TransCam™ photo identification solutions tailored to the particular needs of the identification and security market.
The ID security and access control industries have unique requirements for image capture systems. Cameras must be high-quality and low-cost, produce quality images in all lighting conditions, and able to interface with specialized badge design software for instant creation and issuance of identification credentials. These systems must also be designed for portable use in multiple locations such as a school district, and for permanent installation at a central location, such as a corporate security office. TransTech Systems has recognized these needs and designed two unique camera kits under the TransCam™ brand name. These two unique camera kits are available for immediate distribution.
The TransCam WDM camera kit is designed for portability and includes both a top-of-the-line 8 megapixel high-definition compact camera for capturing crisp and vibrant images of the subject, and TWAIN-driver software solution. The camera can be controlled directly from the user's computer to capture the perfect photo, and the integrated face-finder combined with auto-crop ensures that ID badges are created quickly and professionally.
The TransCam ACK camera kit is designed for high-volume badge issuance. This kit combines a versatile camera from a leading camera manufacturer with a unique TWAIN-driver software solution that provides the user direct control of camera features such as zoom and focus without leaving the workstation to make adjustments.
The TransCam™ camera kits are compatible with the most popular ID Badging solutions in the industry. Deluxe versions of the TransCam kits are also available, offering a high-quality blue/gray reversible backdrop and full-size tripod for use with the camera's integrated tripod mount.
About Visualant, Inc.
Visualant, Inc. (OTCBB: VSUL) develops low-cost, high speed, light-based security and quality control solutions for use in homeland security, anti-counterfeiting, forgery/fraud prevention, brand protection and process control applications. Our patent-pending technology uses controlled illumination with specific bands of light, to establish a unique spectral signature for both individual and classes of items. When matched against existing databases, these spectral signatures allow precise identification and authentication of any item or substance. This breakthrough optical sensing and data capture technology is called Spectral Pattern Matching ("SPM"). SPM technology can be miniaturized and is easily integrated into a variety of hand-held or fixed mount configurations, and can be combined in the same package as a bar-code or biometric scanner.
Through its wholly owned subsidiary, TransTech Systems, Inc., the Company provides security and authentication solutions to security and law enforcement markets throughout the United States.
Contact:
Visualant, Inc.:
Lynn Felsinger
206 903 1351
Lynn@visualant.net
Investor Relations
Paul DeRiso
Core Consulting Group
925-465-6088
paul@coreconsultingroup.com
Visualant, Inc. (OTCBB:VSUL) Featured showcase company on Investorideas.com and related security portals and blogs
Visit the showcase page: http://www.investorideas.com/CO/VSUL/
Disclosure and Disclaimer: Visualant, Inc. (OTCBB:VSUL) is a paid advertising featured showcase company on Investorideas.com and related security portals and blogs.
(1500 per month and $five thousand per month in restricted 144 shares)
China Stocks Directory, Agriculture Stocks, Cloud Computing Stocks
and Social Networking Stocks Directories now Part of Investor Ideas
Membership
POINT ROBERTS, Wash., April 26, 2011 - www.InvestorIdeas.com, a global investor research
portal, specializing in sector research, reports recent additions to the Investor Ideas member
content include the China stocks directory, agriculture stocks directory in addition to the tech
stocks directory featuring cloud computing stocks and social networking stocks.
The most recently added updated directory for members is the China Stocks Directory. The
directory Includes Chinese solar stocks, Chinese biotech stocks, mining stocks , with listed
Companies on the Hong Kong, China, TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX,
AIM and other leading Stock Exchanges. The directory includes a list of over 400 stocks and
growing each month.
http://www.investorideas.com/Companies/China-AsiaStocks/Stocks_List.asp
Investorideas.com members now gain access to 13 leading stock directories, including one of the
largest green and renewable energy stocks directory online, featuring over 1200 green publicly
traded companies.
Investorideas.com covers leading sectors for investors with research tools including stock
directories, news, articles and featured stocks within each sector.
Sectors covered include oil and gas, natural gas, defense, biotech, mining, nanotech, water, tech,
agriculture and other high profile sectors.
The agriculture stocks directory is one of the most visited pages on the site as global food
concerns and food prices rise.
Preview the agriculture stocks directory: http://www.investorideas.com/MSS/Arg_Stock_List.asp
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/
membership/
Additional stock directories at Investorideas.com for investors:
Renewable Energy Stocks Directory - Global Green and Renewable Energy Stocks Directory
in PDF format includes over 1200 stocks on the TSX, TSX Venture, OTC, NASDAQ, AMEX,
NYSE, ASX, AIM and other leading global Stock Exchanges . The directory features hyperlinks
to stocks symbol(s), company’s URL and company’s description. The directory includes info
and links on Alternative Energy Funds, Biogas and Ethanol Stocks, Energy Efficiency Stocks,
Flywheel Stocks, Fuel Cell Stocks, Geothermal Stocks, Hydrogen Production, Micro Turbine
Stocks, Solar Stocks, Smart Grid Stocks, Green Transportation, Wind Power and Wind Energy
Stocks and Green Infrastructure Stocks. For investors following green stocks, this is the most
comprehensive global stock directory online.
Mining and Gold Stocks Directory - Global Mining and Gold Stocks Directory in PDF format
lists over 1100 publicly traded mining companies. Mining and metals investors can research gold
and mining stocks with the mining stocks directory, featuring Gold Stocks, Silver Stocks, Uranium
Stocks, Copper Stocks, Zinc Stocks and Precious Metals TSX, TSX Venture, OTC, NASDAQ,
AMEX, NYSE, ASX, AIM and other leading Stock Exchanges. directory features hyperlinks to
stocks symbol(s), company’s URL and company’s description.
Oil and Gas Stocks Directory - Global Oil and Gas Stocks Directory of Publicly traded oil
and gas stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and
other leading global Stock Exchanges. The comprehensive directory gives investors a full range
and choice of micro cap to large cap stocks in the energy sector. The directory in PDF format,
features hyperlinks to over 600 stocks symbol(s), company's URL and company's description.
Coal Stocks Directory - Global Directory of Publicly traded Coal stocks listed on the TSX,
TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM, China and other leading global Stock
Exchanges . The comprehensive directory gives investors a full range and choice of micro cap
to large cap stocks in the coal sector, including clean coal and coking coal stocks. The directory
in PDF format, features hyperlinks to coal stocks symbol(s), company's URL and company's
description.
Defense Stocks Directory - Global Defense and Homeland Security Stocks Directory features
publicly traded defense stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE,
ASX, AIM and other leading global Stock Exchanges. The directory, in PDF format, includes
Homeland Security Stocks, Aerospace and Defense Stocks, Biodefense Stocks, Security
Stocks, Energy Security Stocks and Infrastructure Stocks with hyperlinks to stocks symbol(s),
company's URL and company's description. For defense stocks followers, this is one of the most
comprehensive global stock directories available to investors.
Water Stocks Directory - Global Water Stocks Directory of publicly traded water stocks listed
on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global
Stock Exchanges. The stock directory features water stocks ranging from desalination companies
to bottled water stocks, to infrastructure, water treatment and technology as well as other
sub sectors. The directory in PDF format, features hyperlinks to stocks symbol(s), company's
URL and company's description. For investors following water stocks this is one of the most
comprehensive directories in the sector available.
Environment Stocks Directory - Global Green Stocks Directory of Publicly traded
Environmental Stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM
and other leading global Stock Exchanges. The directory in PDF format, features hyperlinks to
stocks symbol(s), company's URL and company's description.
Fuel Cell Stocks Directory - Global Directory of Publicly traded Fuel Cell Stocks listed on the
TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock
Exchanges. The directory includes small cap, micro cap as well as large cap NYSE listed stocks
for review. For green investors looking for opportunities in the fuel cell sector, the comprehensive
global directory in PDF format provides a great research tool with hyperlinks to stocks symbol(s),
company's URL and company's description.
Biotech Stocks Directory - Global Directory of Publicly Traded Biotech,Pharma and Life
Sciences Stocks ,on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and
other leading global Stock Exchanges . The directory covers all sub sectors of biotech including
nanotech, biodefense and stem cell stocks. The directory includes small cap, micro cap as well
as large cap NYSE listed stocks for investors The comprehensive global directory in PDF format
provides a great research tool for biotechnology investors with hyperlinks to stocks symbol(s),
company's URL and company's description.
Natural Gas Stocks Directory - Global Directory of Publicly traded Natural Gas Stocks listed on
the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock
Exchanges. The directory includes small cap, micro cap as well as large cap NYSE listed stocks
for review. Natural gas stocks included range from LNG, Coal Bed Methane to exploration and
producers in the sector. The directory in PDF format, features hyperlinks to stocks symbol(s),
company's URL and company's description.
Nanotechnology Stocks Directory - Investorideas.com global stock directory of publicly traded
nanotech stocks on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM, Hong
Kong and China and other leading Stock Exchanges. Directory includes nanotech- biotech
companies, nanotech water and renewable energy companies and more. Directory features
company description, stock symbol and hyperlink to recent quote and info, link to website and
more.
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/
membership/
Sign up for the free investor news letter and get stock alerts in leading
sectors! http://www.investorideas.com/Resources/Newsletter.asp
About InvestorIdeas.com:
Investor Ideas is a global financial media online destination specialized in sector investing
content.
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly,
but we offer no guarantees as to the accuracy of information presented. All Information relating to
featured companies is sourced from public documents and/ or the company and is not the opinion
of our web sites. This site is currently compensated by featured companies, news submissions
and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
For Additional Information and or interest in becoming a content /revenue partner:
Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com
Source – Investorideas.com
and Social Networking Stocks Directories now Part of Investor Ideas
Membership
POINT ROBERTS, Wash., April 26, 2011 - www.InvestorIdeas.com, a global investor research
portal, specializing in sector research, reports recent additions to the Investor Ideas member
content include the China stocks directory, agriculture stocks directory in addition to the tech
stocks directory featuring cloud computing stocks and social networking stocks.
The most recently added updated directory for members is the China Stocks Directory. The
directory Includes Chinese solar stocks, Chinese biotech stocks, mining stocks , with listed
Companies on the Hong Kong, China, TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX,
AIM and other leading Stock Exchanges. The directory includes a list of over 400 stocks and
growing each month.
http://www.investorideas.com/Companies/China-AsiaStocks/Stocks_List.asp
Investorideas.com members now gain access to 13 leading stock directories, including one of the
largest green and renewable energy stocks directory online, featuring over 1200 green publicly
traded companies.
Investorideas.com covers leading sectors for investors with research tools including stock
directories, news, articles and featured stocks within each sector.
Sectors covered include oil and gas, natural gas, defense, biotech, mining, nanotech, water, tech,
agriculture and other high profile sectors.
The agriculture stocks directory is one of the most visited pages on the site as global food
concerns and food prices rise.
Preview the agriculture stocks directory: http://www.investorideas.com/MSS/Arg_Stock_List.asp
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/
membership/
Additional stock directories at Investorideas.com for investors:
Renewable Energy Stocks Directory - Global Green and Renewable Energy Stocks Directory
in PDF format includes over 1200 stocks on the TSX, TSX Venture, OTC, NASDAQ, AMEX,
NYSE, ASX, AIM and other leading global Stock Exchanges . The directory features hyperlinks
to stocks symbol(s), company’s URL and company’s description. The directory includes info
and links on Alternative Energy Funds, Biogas and Ethanol Stocks, Energy Efficiency Stocks,
Flywheel Stocks, Fuel Cell Stocks, Geothermal Stocks, Hydrogen Production, Micro Turbine
Stocks, Solar Stocks, Smart Grid Stocks, Green Transportation, Wind Power and Wind Energy
Stocks and Green Infrastructure Stocks. For investors following green stocks, this is the most
comprehensive global stock directory online.
Mining and Gold Stocks Directory - Global Mining and Gold Stocks Directory in PDF format
lists over 1100 publicly traded mining companies. Mining and metals investors can research gold
and mining stocks with the mining stocks directory, featuring Gold Stocks, Silver Stocks, Uranium
Stocks, Copper Stocks, Zinc Stocks and Precious Metals TSX, TSX Venture, OTC, NASDAQ,
AMEX, NYSE, ASX, AIM and other leading Stock Exchanges. directory features hyperlinks to
stocks symbol(s), company’s URL and company’s description.
Oil and Gas Stocks Directory - Global Oil and Gas Stocks Directory of Publicly traded oil
and gas stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and
other leading global Stock Exchanges. The comprehensive directory gives investors a full range
and choice of micro cap to large cap stocks in the energy sector. The directory in PDF format,
features hyperlinks to over 600 stocks symbol(s), company's URL and company's description.
Coal Stocks Directory - Global Directory of Publicly traded Coal stocks listed on the TSX,
TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM, China and other leading global Stock
Exchanges . The comprehensive directory gives investors a full range and choice of micro cap
to large cap stocks in the coal sector, including clean coal and coking coal stocks. The directory
in PDF format, features hyperlinks to coal stocks symbol(s), company's URL and company's
description.
Defense Stocks Directory - Global Defense and Homeland Security Stocks Directory features
publicly traded defense stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE,
ASX, AIM and other leading global Stock Exchanges. The directory, in PDF format, includes
Homeland Security Stocks, Aerospace and Defense Stocks, Biodefense Stocks, Security
Stocks, Energy Security Stocks and Infrastructure Stocks with hyperlinks to stocks symbol(s),
company's URL and company's description. For defense stocks followers, this is one of the most
comprehensive global stock directories available to investors.
Water Stocks Directory - Global Water Stocks Directory of publicly traded water stocks listed
on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global
Stock Exchanges. The stock directory features water stocks ranging from desalination companies
to bottled water stocks, to infrastructure, water treatment and technology as well as other
sub sectors. The directory in PDF format, features hyperlinks to stocks symbol(s), company's
URL and company's description. For investors following water stocks this is one of the most
comprehensive directories in the sector available.
Environment Stocks Directory - Global Green Stocks Directory of Publicly traded
Environmental Stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM
and other leading global Stock Exchanges. The directory in PDF format, features hyperlinks to
stocks symbol(s), company's URL and company's description.
Fuel Cell Stocks Directory - Global Directory of Publicly traded Fuel Cell Stocks listed on the
TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock
Exchanges. The directory includes small cap, micro cap as well as large cap NYSE listed stocks
for review. For green investors looking for opportunities in the fuel cell sector, the comprehensive
global directory in PDF format provides a great research tool with hyperlinks to stocks symbol(s),
company's URL and company's description.
Biotech Stocks Directory - Global Directory of Publicly Traded Biotech,Pharma and Life
Sciences Stocks ,on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and
other leading global Stock Exchanges . The directory covers all sub sectors of biotech including
nanotech, biodefense and stem cell stocks. The directory includes small cap, micro cap as well
as large cap NYSE listed stocks for investors The comprehensive global directory in PDF format
provides a great research tool for biotechnology investors with hyperlinks to stocks symbol(s),
company's URL and company's description.
Natural Gas Stocks Directory - Global Directory of Publicly traded Natural Gas Stocks listed on
the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock
Exchanges. The directory includes small cap, micro cap as well as large cap NYSE listed stocks
for review. Natural gas stocks included range from LNG, Coal Bed Methane to exploration and
producers in the sector. The directory in PDF format, features hyperlinks to stocks symbol(s),
company's URL and company's description.
Nanotechnology Stocks Directory - Investorideas.com global stock directory of publicly traded
nanotech stocks on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM, Hong
Kong and China and other leading Stock Exchanges. Directory includes nanotech- biotech
companies, nanotech water and renewable energy companies and more. Directory features
company description, stock symbol and hyperlink to recent quote and info, link to website and
more.
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/
membership/
Sign up for the free investor news letter and get stock alerts in leading
sectors! http://www.investorideas.com/Resources/Newsletter.asp
About InvestorIdeas.com:
Investor Ideas is a global financial media online destination specialized in sector investing
content.
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly,
but we offer no guarantees as to the accuracy of information presented. All Information relating to
featured companies is sourced from public documents and/ or the company and is not the opinion
of our web sites. This site is currently compensated by featured companies, news submissions
and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
For Additional Information and or interest in becoming a content /revenue partner:
Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com
Source – Investorideas.com
Monday, April 25, 2011
TSX Mining Stock Yale Resources Ltd. (TSX-V - YLL) to Present at Online Mining Investor Conference this May
Resource Speakers to include Eric Coffin, Peter Grandich, Lawrence Roulston, Stephen Whiteside
The online mining conference, Follow the Money in Mining and Metals, will be held May 25 th and 26. Industry Speakers include Eric Coffin from Hard Rock Analyst, Peter Grandich, Lawrence Roulston and Stephen Whiteside of TheUpTrend.com.
The online conference is free to investors with login registration. Investors will have the opportunity to hear some of the best in the industry provide insight on the future of mining stocks.
Investor registration:
The presentations will be an audio format with PowerPoint, averaging 10-15 minutes in length.
The event will be pre-recorded and go live May 25 th starting at 9:00 a.m. EST. It will be archived for three months and available with login. The conference pages will be featured for investors at both Investorideas.com and SmallCapvoice.com.
Learn More about the Mining Conference
http://www.investorideas.com/MSS/Conference.asp
Free Investor Sign-Up
http://www.smallcapvoice.com/ii_scv/investor-signup.html
Public Company Sign-Up
http://www.smallcapvoice.com/ii_scv/company-signup.html
Mining Stocks:
Yale Resources Ltd . (( TSX-V - YLL and Frankfurt - YAB) is an exploration and development company building value utilizing the Project Generator business model. With its Mexican operations based out of Hermosillo, Sonora, Yale is utilizing its extensive Mexican network to identify, acquire and advance projects of merit. Yale's partners are scheduled to spend greater than $1,000,000 on exploration on the Company's properties over the next 12 months. http://www.yaleresources.com/
Speaker: Ian Foreman
Contact: info@yaleresources.com
Running Fox (OTC.PK: RFXRF) (TSX-V: RUN)
Running Fox (TSX-V:RUN) (US OTC:RFXRF) (FRANKFURT:C8Q) is a Canadian growth-oriented resource company with mineral projects including US uranium and Canadian gold properties, oil and gas assets, and oilfield service operations.
www.foxgold.ca
Speakers:
Peter Grandich
Grandich is the founder of Grandich.com and Grandich Publications, LLC, and is editor of The Grandich Letter which was first published in 1984. On his internationally-followed blog, he comments daily about the world's economies and financial markets and posts his views on social and political topics. He also blogs about a variety of timely subjects of general interest and interweaves his unique brand of humor and every-man "Grandichism" expressions with his experience gained from more than 25 years in and around Wall Street. The result is an insightful and intuitive look at business, finances and the world, set in a vernacular that just about anyone can understand. In his first year, Grandich's wildly-popular blog had more than one million views. Grandich also provides a variety of services to publicly-held corporations on a compensation basis.
Lawrence Roulston
Roulston, editor, is a geologist, with engineering and business training, and more than 20 years of hands-on experience in the resource industry. Lawrence is ideally suited to publish Resource Opportunities. After completing his studies at the University of British Columbia in 1975, Mr. Roulston worked as an analyst for Cominco Ltd. and for a mid-sized Calgary oil group for several years. In 1984 he became the CFO for a group of mineral exploration companies. He was also vice-president in an investment management firm focused on the resource industry. From 1994 to 1997, he was CEO and director of a mineral exploration company.
http://www.resourceopportunities.com
Stephen Whiteside
Stephen Whiteside is the CEO of Whiteside Analytics, and founder of www.TheUpTrend.com.
Stephen started trading commodities in 1984 and became heavily involved in technical analysis in 1987. In 1999, Stephen started sharing his proprietary charts online and attracted an online following. As his online following grew, Stephen started his online charting service TheUpTrend.com in 2001. Currently, TheUpTremd.com has clients in 43 countries and provides daily analysis on over 2,000 of the most actively traded stocks, indexes, ETF's and commodities.
Eric Coffin
Hard Rock Analyst
http://www.hraadvisory.com/
Eric is the "financial analysis" side of the Hard Rock Analyst team and holds a degree in Corporate and Investment Finance. He has extensive experience in merger and acquisitions and small company financing and promotion. For many years he tracked the financial performance and funding of all exchange listed Canadian mining companies and has helped with the formation of several successful exploration ventures.
Eric has been interviewed on national and local TV and radio in Canada and the US for his opinions on resource trends and is a frequent contributor to several third party publications and a number of resource, gold, metals and market related Internet sites.
He regularly speaks at a number of North American gold and resource conferences. He was one of the first analysts (along with brother David) to point out the disastrous effects of gold hedging and gold loan capital financing (1997) and to predict the start of the current secular bull market in commodities based on the movement of the US Dollar (2001) and the acceleration of growth in Asia and India.
Eric reviews data from hundreds of companies seeking strong management and finance teams in undiscovered companies for HRA's readers. Combined with good share structures and projects that David likes, these companies have the potential to make the HRA list and generate gains for their readers.
About our Mining Portals:
www.Gold-MiningStocks.com and www.MiningSectorStocks.com are research portals within the InvestorIdeas.com content umbrella, featuring industry and stock news, exclusive articles and financial columnists, audio interviews and podcasts, investor conferences, blogs, and a directory of over 1200 mining stocks.
About InvestorIdeas.com: Investor Ideas that Can Change the World
Investor Ideas is a global financial media online destination specialized in sector investing content including mining and energy stocks.
About SmallCapVoice.com, Inc.: Specializing in Covering Small Cap Stocks & Providing Small Cap Investor Relations
Recognized corporate investor relations firm SmallCapVoice.com, Inc. is known for its ability to help emerging growth companies build a following among retail and institutional investors.
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
Disclosure: YLL is also a featured showcase stock on Investorideas.com
Learn more: http://www.investorideas.com/About/News/Clientspecifics.asp
For info on presenting as a public company, speaker or media sponsor contact
Cali Van Zant: 800-665-0411 - cvanzant@investorideas.com
Stuart T. Smith CEO
512-267-2430
ssmith@smallcapvoice.com
Source - Investorideas.com, SmallCapVoice.com
Visit the YLL showcase profile at Investorideas.com
Request News and Info on YLL
Disclosure, Disclaimer/ YLL is a paid advertising client on Investorideas.com and our mining portals.
Request News and Info on YLL
Disclosure, Disclaimer/ YLL is a paid advertising client on Investorideas.com and our mining portals.
Thursday, April 21, 2011
Nanotechnology Stocks; mPhase Technologies (OTC.BB:XDSL) Developing Battery for G-Force Activated Application
LITTLE FALLS, NJ - April 21, 2011 (Investorideas.com Newswire) - mPhase Technologies, Inc. (OTC.BB:XDSL) today announced that it is engaged in the preliminary discussions with a major prime contractor of military applications to potentially adapt its battery technology and reserve battery �know-how" to serve as a G-force activated energy source to provide power in new weapons systems. The Company has successfully tested with the U.S. Army in the past, a single-cell reserve battery, which was activated by a projectile launch event, fired out of a tank, at the Aberdeen Proving Grounds in Maryland, in 2008. The Company has since expanded its efforts to a multi-cell capability for non-G-force enabled applications such as memory backup and is improving this advanced design for critical G-force enabled munitions systems. Additionally, mPhase is seeking to expand its initial efforts with Picatinny Arsenal in developing applications of its Smart NanoBattery to provide power for smart munitions. The Company recently signed a 3 year CRADA (Cooperative Research and Development Agreement) with the U.S. Army Armament Research, Development, and Engineering Center (ARDEC) at Picatinny, New Jersey.
"We believe we are making significant strides in establishing key partnerships for a broad development effort of batteries capable of being activated by G-force acceleration. Reliable and safe energy sources for providing power are essential to many new weapons systems, especially small munitions systems," said Ron Durando, president and CEO of mPhase Technologies. "We are looking forward to establishing a significant collaboration effort with other prime military contractors."
Prior testing with Picatinny demonstrated extreme resiliency to shock and acceleration of the SmartBattery prototypes, surviving tests that subjected them to high acceleration of over 30,000 G-forces. (One G is equal to the pull of gravity at sea level). The tests, which involved both simulations out of an air-gun and live testing of firing projectiles out of a tank, indicated that the underlying nanostructure of the prototype power cell could withstand extreme shock if used in military applications.
About mPhase Technologies, Inc.
mPhase Technologies is introducing a revolutionary Smart Surface technology enabled by breakthroughs in nanotechnology, MEMS processing and microfluidics. Our Smart Surface technology has potential applications within drug delivery systems, lab on a chip analytic systems, self cleaning systems, liquid and chemical sensor systems, and filtration systems. mPhase has pioneered its first Smart Surface enabled product, the mPhase Smart NanoBattery.
In addition to the Smart Surface technology, mPhase recently introduced its first product, the mPower Emergency Illuminator, an award-winning product designed by Porsche Design Studio. http://www.mpowertech.com
Forward Looking Statements
As a cautionary note to investors, certain matters discussed in this press release may be forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company s products in the market; the Company s success in technology and product development; the Company s ability to execute its business model and strategic plans; and all the risks and related information described from time to time in the Company s SEC filings, including the financial statements and related information contained in the Company s SEC Filing. mPhase assumes no obligation to update the information in this release.
Contact:
mPhase Technologies, Inc. 973 256 3737
LITTLE FALLS, NJ - April 21, 2011 (Investorideas.com Newswire) - mPhase Technologies, Inc. (OTC.BB:XDSL) today announced that it is engaged in the preliminary discussions with a major prime contractor of military applications to potentially adapt its battery technology and reserve battery �know-how" to serve as a G-force activated energy source to provide power in new weapons systems. The Company has successfully tested with the U.S. Army in the past, a single-cell reserve battery, which was activated by a projectile launch event, fired out of a tank, at the Aberdeen Proving Grounds in Maryland, in 2008. The Company has since expanded its efforts to a multi-cell capability for non-G-force enabled applications such as memory backup and is improving this advanced design for critical G-force enabled munitions systems. Additionally, mPhase is seeking to expand its initial efforts with Picatinny Arsenal in developing applications of its Smart NanoBattery to provide power for smart munitions. The Company recently signed a 3 year CRADA (Cooperative Research and Development Agreement) with the U.S. Army Armament Research, Development, and Engineering Center (ARDEC) at Picatinny, New Jersey.
"We believe we are making significant strides in establishing key partnerships for a broad development effort of batteries capable of being activated by G-force acceleration. Reliable and safe energy sources for providing power are essential to many new weapons systems, especially small munitions systems," said Ron Durando, president and CEO of mPhase Technologies. "We are looking forward to establishing a significant collaboration effort with other prime military contractors."
Prior testing with Picatinny demonstrated extreme resiliency to shock and acceleration of the SmartBattery prototypes, surviving tests that subjected them to high acceleration of over 30,000 G-forces. (One G is equal to the pull of gravity at sea level). The tests, which involved both simulations out of an air-gun and live testing of firing projectiles out of a tank, indicated that the underlying nanostructure of the prototype power cell could withstand extreme shock if used in military applications.
About mPhase Technologies, Inc.
mPhase Technologies is introducing a revolutionary Smart Surface technology enabled by breakthroughs in nanotechnology, MEMS processing and microfluidics. Our Smart Surface technology has potential applications within drug delivery systems, lab on a chip analytic systems, self cleaning systems, liquid and chemical sensor systems, and filtration systems. mPhase has pioneered its first Smart Surface enabled product, the mPhase Smart NanoBattery.
In addition to the Smart Surface technology, mPhase recently introduced its first product, the mPower Emergency Illuminator, an award-winning product designed by Porsche Design Studio. http://www.mpowertech.com
Forward Looking Statements
As a cautionary note to investors, certain matters discussed in this press release may be forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company s products in the market; the Company s success in technology and product development; the Company s ability to execute its business model and strategic plans; and all the risks and related information described from time to time in the Company s SEC filings, including the financial statements and related information contained in the Company s SEC Filing. mPhase assumes no obligation to update the information in this release.
Contact:
mPhase Technologies, Inc. 973 256 3737
Visit the XDSL showcase profile at Investorideas.com
Request News and Info on XDSL
Disclosure, Disclaimer/ XDSL is a paid advertising client on Investorideas.com and our technology portals.
Request News and Info on XDSL
Disclosure, Disclaimer/ XDSL is a paid advertising client on Investorideas.com and our technology portals.
Investing in Cleantech For Earth Day
Wind Company Snapshot; Clean Wind Energy Tower, Inc. (OTCBB: CWET)
POINT ROBERTS, Wash., April 21 2011 - www.InvestorIdeas.com, a global investor research
portal, specializing in sector research including cleantech stocks, issues a wind company
snapshot for Clean Wind Energy Tower, Inc. (OTCBB: CWET).
Investorideas.com is one of the first investor websites offering research tools for independent
investors covering renewable energy stocks and water stocks.
Investorideas.com provides investors with comprehensive stock directories including the
renewable energy stocks directory, listing over 1200 publicly traded green stocks.
Wind Company Snapshot
Clean Wind Energy Tower, Inc. (OTCBB: CWET)
Clean Wind Energy, Inc., a wholly owned subsidiary of Clean Wind Energy Tower, Inc., was
established to commercialize a number of proven and validated technologies and construction
systems into a single large downdraft tower structure that use benevolent, non-toxic natural
elements to generate electricity and clean water economically by integrating and synthesizing
numerous proven as well as emerging technologies. In addition to constructing Downdraft Towers
in the United States and abroad, Clean Wind Energy, Inc. has assembled a world class team of
experienced business professionals, engineers and scientists with access to the breakthrough
energy research upon which this technology is founded and the proven ability to bring the idea to
market.
Clean Wind has filed several patents that the Company believes will further enhance this
potentially revolutionary technology. The Company intends to establish partnerships at home
and abroad to propagate these systems and meet increasing global demand for clean water and
electricity.
www.cleanwindenergytower.com
Visit the showcase page at Investorideas.com: http://www.investorideas.com/CO/CWE/
Research more wind stocks with the renewable energy stocks directory:
http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp
Current list of cleantech stock directories at Investorideas.com for
investors:
Renewable Energy Stocks Directory - Global Green and Renewable Energy
Stocks Directory in PDF format includes over 1200 stocks on the TSX, TSX
Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global
Stock Exchanges . The directory features hyperlinks to stocks symbol(s),
company’s URL and company’s description. The directory includes info and links
on Alternative Energy Funds, Biogas and Ethanol Stocks, Energy Efficiency
Stocks, Flywheel Stocks, Fuel Cell Stocks, Geothermal Stocks, Hydrogen
Production, Micro Turbine Stocks, Solar Stocks, Smart Grid Stocks, Green
Transportation, Wind Power and Wind Energy Stocks and Green Infrastructure
Stocks. For investors following green stocks, this is the most comprehensive
global stock directory online.
Water Stocks Directory - Global Water Stocks Directory of publicly traded water
stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX,
AIM and other leading global Stock Exchanges. The stock directory features
water stocks ranging from desalination companies to bottled water stocks, to
infrastructure, water treatment and technology as well as other sub sectors. The
directory in PDF format, features hyperlinks to stocks symbol(s), company's URL
and company's description. For investors following water stocks this is one of the
most comprehensive directories in the sector available.
Environment Stocks Directory - Global Green Stocks Directory of Publicly
traded Environmental Stocks listed on the TSX, TSX Venture, OTC, NASDAQ,
AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The
directory in PDF format, features hyperlinks to stocks symbol(s), company's URL
and company's description.
Fuel Cell Stocks Directory - Global Directory of Publicly traded Fuel Cell
Stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX,
AIM and other leading global Stock Exchanges. The directory includes small
cap, micro cap as well as large cap NYSE listed stocks for review. For green
investors looking for opportunities in the fuel cell sector, the comprehensive
global directory in PDF format provides a great research tool with hyperlinks to
stocks symbol(s), company's URL and company's description.
Visit the Investor Ideas membership page to learn more at: http://
www.investorideas.com/membership/
Sign up for the free investor news letter and get stock alerts in leading
sectors! http://www.investorideas.com/Resources/Newsletter.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors
we cover include; cleantech and renewable energy stocks, biotech stocks,
mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech,
agriculture and gaming.
Disclaimer/ Disclosure: The following news is part of the Clean Wind Energy Tower, Inc. (OTCBB: CWET)
advertising program with Investorideas.com. Clean Wind Energy, Inc. compensates investorideas.com
(one thousand five hundred per month, 100,000 144 shares) to be showcased as a renewable energy stock
within its hub of sites and blogs.Our sites do not make recommendations. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly,
but we offer no guarantees as to the accuracy of information presented. All Information relating to featured
companies is sourced from public documents and/ or the company and its management and is not the
opinion of Investorideas.com.
Learn more: www.InvestorIdeas.com/About/Disclaimer.asp
For Additional Information and or interest in becoming a content /revenue
partner:
Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com
Source – Investorideas.com
Wind Company Snapshot; Clean Wind Energy Tower, Inc. (OTCBB: CWET)
POINT ROBERTS, Wash., April 21 2011 - www.InvestorIdeas.com, a global investor research
portal, specializing in sector research including cleantech stocks, issues a wind company
snapshot for Clean Wind Energy Tower, Inc. (OTCBB: CWET).
Investorideas.com is one of the first investor websites offering research tools for independent
investors covering renewable energy stocks and water stocks.
Investorideas.com provides investors with comprehensive stock directories including the
renewable energy stocks directory, listing over 1200 publicly traded green stocks.
Wind Company Snapshot
Clean Wind Energy Tower, Inc. (OTCBB: CWET)
Clean Wind Energy, Inc., a wholly owned subsidiary of Clean Wind Energy Tower, Inc., was
established to commercialize a number of proven and validated technologies and construction
systems into a single large downdraft tower structure that use benevolent, non-toxic natural
elements to generate electricity and clean water economically by integrating and synthesizing
numerous proven as well as emerging technologies. In addition to constructing Downdraft Towers
in the United States and abroad, Clean Wind Energy, Inc. has assembled a world class team of
experienced business professionals, engineers and scientists with access to the breakthrough
energy research upon which this technology is founded and the proven ability to bring the idea to
market.
Clean Wind has filed several patents that the Company believes will further enhance this
potentially revolutionary technology. The Company intends to establish partnerships at home
and abroad to propagate these systems and meet increasing global demand for clean water and
electricity.
www.cleanwindenergytower.com
Visit the showcase page at Investorideas.com: http://www.investorideas.com/CO/CWE/
Research more wind stocks with the renewable energy stocks directory:
http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp
Current list of cleantech stock directories at Investorideas.com for
investors:
Renewable Energy Stocks Directory - Global Green and Renewable Energy
Stocks Directory in PDF format includes over 1200 stocks on the TSX, TSX
Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global
Stock Exchanges . The directory features hyperlinks to stocks symbol(s),
company’s URL and company’s description. The directory includes info and links
on Alternative Energy Funds, Biogas and Ethanol Stocks, Energy Efficiency
Stocks, Flywheel Stocks, Fuel Cell Stocks, Geothermal Stocks, Hydrogen
Production, Micro Turbine Stocks, Solar Stocks, Smart Grid Stocks, Green
Transportation, Wind Power and Wind Energy Stocks and Green Infrastructure
Stocks. For investors following green stocks, this is the most comprehensive
global stock directory online.
Water Stocks Directory - Global Water Stocks Directory of publicly traded water
stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX,
AIM and other leading global Stock Exchanges. The stock directory features
water stocks ranging from desalination companies to bottled water stocks, to
infrastructure, water treatment and technology as well as other sub sectors. The
directory in PDF format, features hyperlinks to stocks symbol(s), company's URL
and company's description. For investors following water stocks this is one of the
most comprehensive directories in the sector available.
Environment Stocks Directory - Global Green Stocks Directory of Publicly
traded Environmental Stocks listed on the TSX, TSX Venture, OTC, NASDAQ,
AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The
directory in PDF format, features hyperlinks to stocks symbol(s), company's URL
and company's description.
Fuel Cell Stocks Directory - Global Directory of Publicly traded Fuel Cell
Stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX,
AIM and other leading global Stock Exchanges. The directory includes small
cap, micro cap as well as large cap NYSE listed stocks for review. For green
investors looking for opportunities in the fuel cell sector, the comprehensive
global directory in PDF format provides a great research tool with hyperlinks to
stocks symbol(s), company's URL and company's description.
Visit the Investor Ideas membership page to learn more at: http://
www.investorideas.com/membership/
Sign up for the free investor news letter and get stock alerts in leading
sectors! http://www.investorideas.com/Resources/Newsletter.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors
we cover include; cleantech and renewable energy stocks, biotech stocks,
mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech,
agriculture and gaming.
Disclaimer/ Disclosure: The following news is part of the Clean Wind Energy Tower, Inc. (OTCBB: CWET)
advertising program with Investorideas.com. Clean Wind Energy, Inc. compensates investorideas.com
(one thousand five hundred per month, 100,000 144 shares) to be showcased as a renewable energy stock
within its hub of sites and blogs.Our sites do not make recommendations. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly,
but we offer no guarantees as to the accuracy of information presented. All Information relating to featured
companies is sourced from public documents and/ or the company and its management and is not the
opinion of Investorideas.com.
Learn more: www.InvestorIdeas.com/About/Disclaimer.asp
For Additional Information and or interest in becoming a content /revenue
partner:
Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com
Source – Investorideas.com
Biotech/Biodefense Stock News; Aethlon Medical (OTCBB: AEMD) Clarifies News Report
SAN DIEGO - April 21, 2011 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB: AEMD) disclosed that it was the subject of an ABC affiliate station news story that included discussion of the company's proposed strategy to reduce the occurrence of sepsis in wounded military personnel. As previously disclosed, the company submitted a contract response on April 1, 2011 to a Broad Agency Announcement (BAA) entitled Dialysis Like Therapeutics (DLT). In the submission, company proposed multiple capabilities including the development of dialysis-like therapy that would address the objectives of the DLT program. The company wishes to clarify that there is no assurance it will be invited to participate in the DLT program and that battlefield deployment of such a device is not feasible in the near future as suggested in the ABC affiliate news story. However, the company does believe that successful clinical outcomes in treating Hepatitis-C (HCV) infected patients with its Hemopurifier� technology does offer the potential for an early commercialization pathway of its Hemopurifier� in India. The company appreciates the coverage by the ABC news affiliate which unfortunately confused the potential commercialization timeline of our Hemopurifier� with the device proposed to be developed in our DLT response.
About Aethlon Medical
At Aethlon Medical, we create revolutionary devices to address infectious disease and cancer. Our devices are designed to be novel platform solutions that fill therapeutic voids or aid in disease diagnosis and monitoring.
Our Hemopurifier® is the first medical device to selectively target the removal of infectious viruses and immunosuppressive proteins from the entire circulatory system. We recently discovered that our Hemopurifier® captures tumor-secreted exosomes that suppress the immune system of those afflicted with cancer. Prior to this discovery, a therapeutic strategy to directly inhibit or reverse the immunosuppressive destruction caused by exosomes did not exist in cancer care. By eliminating this mechanism, we believe our Hemopurifier® can fill an unmet clinical need and provide the benefit of an immune-based therapy without adding drug toxicity or interaction risks to established and emerging treatment strategies.
Human studies have documented the ability of our Hemopurifier® to safely reduce viral load in both Hepatitis-C virus (HCV) and Human Immunodeficiency Virus (HIV) infected patients without the administration of antiviral drugs. However, our initial clinical and commercialization focus is to establish our Hemopurifier® as an adjunct therapy to enhance the benefit of both infectious disease and cancer treatment regimens. In this regard, we plan to commercialize our Hemopurifier® in India as we advance our clinical strategies in the United States and the European Union. In vitro studies conducted by government and non-government research institutes have also verified that our Hemopurifier® has broad-spectrum capabilities against bioterror and emerging pandemic threats. These studies have confirmed the capture of Dengue Hemorrhagic Virus, Ebola Hemorrhagic Virus, Lassa Hemorrhagic Virus, West Nile Virus, H5N1 Avian Influenza Virus, 2009 H1N1 Influenza Virus, the reconstructed Spanish Flu of 1918 Virus, and Monkeypox Virus, which serves as a model for human Smallpox infection.
As a therapeutic device, the Hemopurifier® provides us with a pipeline into four significant market opportunities:
In design, our Hemopurifier® is a selective filtration device containing affinity agents that tightly bind to high-mannose structures unique to the surface of exosomes produced by cancer and glycoproteins residing on the envelope of viruses. These agents are immobilized around approximately 2800 porous hollow fibers that run the interior length of our device. The resulting design provides us the novel ability to separate both exosome and viral targets away from blood cells so they can then be selectively and permanently removed from the circulatory system. In application, blood circulation is established into the Hemopurifier® via a catheter or other blood access device. Once blood flow has been established, treatment benefit is immediate as the entire circulatory system can pass through the Hemopurifier® in as little as 15 minutes.
Our wholly owned subsidiary, Exosome Sciences, Inc. (ESI) is focused on the development of exosome-targeted products and services that improve cancer diagnosis, provide post-treatment cancer surveillance, and aid in the discovery of biomarkers that allow doctors to optimize patient therapy. Additional information regarding Aethlon Medical and Exosome Sciences can be accessed online at www.aethlonmedical.com.
Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the company's ability to commercialize its Hemopurifier® in India, capability of the Hemopurifier® to reduce viral loads and other disease conditions or to identify or treat disease conditions such as cancer or Hepatitis-C, including the ability to capture exosomes and the impact that potential ability may have on disease conditions, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the ability of the Company to obtain FDA and other regulatory approvals permitting the sale of its products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings.
Contacts:
James A. Joyce
Chairman, CEO
858.459.7800 x301
jj@aethlonmedical.com
John P. Salvador
Director, Communications & Investor Relations
858.459.7800 x307
jps@aethlonmedical.com
SAN DIEGO - April 21, 2011 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB: AEMD) disclosed that it was the subject of an ABC affiliate station news story that included discussion of the company's proposed strategy to reduce the occurrence of sepsis in wounded military personnel. As previously disclosed, the company submitted a contract response on April 1, 2011 to a Broad Agency Announcement (BAA) entitled Dialysis Like Therapeutics (DLT). In the submission, company proposed multiple capabilities including the development of dialysis-like therapy that would address the objectives of the DLT program. The company wishes to clarify that there is no assurance it will be invited to participate in the DLT program and that battlefield deployment of such a device is not feasible in the near future as suggested in the ABC affiliate news story. However, the company does believe that successful clinical outcomes in treating Hepatitis-C (HCV) infected patients with its Hemopurifier� technology does offer the potential for an early commercialization pathway of its Hemopurifier� in India. The company appreciates the coverage by the ABC news affiliate which unfortunately confused the potential commercialization timeline of our Hemopurifier� with the device proposed to be developed in our DLT response.
About Aethlon Medical
At Aethlon Medical, we create revolutionary devices to address infectious disease and cancer. Our devices are designed to be novel platform solutions that fill therapeutic voids or aid in disease diagnosis and monitoring.
Our Hemopurifier® is the first medical device to selectively target the removal of infectious viruses and immunosuppressive proteins from the entire circulatory system. We recently discovered that our Hemopurifier® captures tumor-secreted exosomes that suppress the immune system of those afflicted with cancer. Prior to this discovery, a therapeutic strategy to directly inhibit or reverse the immunosuppressive destruction caused by exosomes did not exist in cancer care. By eliminating this mechanism, we believe our Hemopurifier® can fill an unmet clinical need and provide the benefit of an immune-based therapy without adding drug toxicity or interaction risks to established and emerging treatment strategies.
Human studies have documented the ability of our Hemopurifier® to safely reduce viral load in both Hepatitis-C virus (HCV) and Human Immunodeficiency Virus (HIV) infected patients without the administration of antiviral drugs. However, our initial clinical and commercialization focus is to establish our Hemopurifier® as an adjunct therapy to enhance the benefit of both infectious disease and cancer treatment regimens. In this regard, we plan to commercialize our Hemopurifier® in India as we advance our clinical strategies in the United States and the European Union. In vitro studies conducted by government and non-government research institutes have also verified that our Hemopurifier® has broad-spectrum capabilities against bioterror and emerging pandemic threats. These studies have confirmed the capture of Dengue Hemorrhagic Virus, Ebola Hemorrhagic Virus, Lassa Hemorrhagic Virus, West Nile Virus, H5N1 Avian Influenza Virus, 2009 H1N1 Influenza Virus, the reconstructed Spanish Flu of 1918 Virus, and Monkeypox Virus, which serves as a model for human Smallpox infection.
As a therapeutic device, the Hemopurifier® provides us with a pipeline into four significant market opportunities:
- Cancer: A treatment candidate to improve patient responsiveness to established cancer therapies by removing immunosuppressive exosomes from circulation.
- Hepatitis-C Virus (HCV): As an adjunct therapy to accelerate viral load reduction at the outset of standard of care drug regimens.
- Human Immunodeficiency Virus (HIV): Provides a potential therapeutic option for HIV-infected individuals to manage disease progression once they become resistant to antiviral drug regimens.
- Bioterror and Pandemic Threats: Represents the most advanced broad-spectrum strategy to address untreatable bioterror and emerging pandemic threats.
In design, our Hemopurifier® is a selective filtration device containing affinity agents that tightly bind to high-mannose structures unique to the surface of exosomes produced by cancer and glycoproteins residing on the envelope of viruses. These agents are immobilized around approximately 2800 porous hollow fibers that run the interior length of our device. The resulting design provides us the novel ability to separate both exosome and viral targets away from blood cells so they can then be selectively and permanently removed from the circulatory system. In application, blood circulation is established into the Hemopurifier® via a catheter or other blood access device. Once blood flow has been established, treatment benefit is immediate as the entire circulatory system can pass through the Hemopurifier® in as little as 15 minutes.
Our wholly owned subsidiary, Exosome Sciences, Inc. (ESI) is focused on the development of exosome-targeted products and services that improve cancer diagnosis, provide post-treatment cancer surveillance, and aid in the discovery of biomarkers that allow doctors to optimize patient therapy. Additional information regarding Aethlon Medical and Exosome Sciences can be accessed online at www.aethlonmedical.com.
Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the company's ability to commercialize its Hemopurifier® in India, capability of the Hemopurifier® to reduce viral loads and other disease conditions or to identify or treat disease conditions such as cancer or Hepatitis-C, including the ability to capture exosomes and the impact that potential ability may have on disease conditions, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the ability of the Company to obtain FDA and other regulatory approvals permitting the sale of its products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings.
Contacts:
James A. Joyce
Chairman, CEO
858.459.7800 x301
jj@aethlonmedical.com
John P. Salvador
Director, Communications & Investor Relations
858.459.7800 x307
jps@aethlonmedical.com
AETHLON MEDICAL INC (OTC BB: AEMD) is a Showcase biotech, biodefense and defense stock on Investorideas.com ($one thousand five hundred per month, $five thousand per month in 144 stock)
Effective March 15, 2011
Effective March 15, 2011
POINT ROBERTS, Wash., April 21 2011 - www.InvestorIdeas.com, a leader in sector stock including tech stocks, issues a cloud computing stock sector snapshot for morning trading following a recent run in several of the stocks in the sector. Rackspace Hosting (NYSE: RAX), a s pecialist in hosting and cloud computing industry, hit a 52 week- high. The sector leader was VMware Inc. (NYSE: VMW ), closing at $97.90, +$11.93, +13.88% on strong quarterly news. The Company reported year-over-year revenue growth of 33% to $844 Million.
Sector Snapshot
http://www.investorideas.com/TSS/Cloud_Computing_Stocks.asp
Market Snapshot:
VMware Reports First Quarter 2011 Results
More: http://www.vmware.com/company/news/releases/vmw-earnings-q111.html
Elephant Talk and Its ValidSoft Subsidiary Featured in Josh Levine's MicroCap Investor Newsletter- Companies Positioned to Profit From "Securing the Mobile Cloud"
SCHIPHOL, THE NETHERLANDS--- Elephant Talk Communications Inc. (OTC.BB: ETAK - News) (http://www.elephanttalk.com) has announced that the company and its wholly-owned subsidiary, ValidSoft Limited, (www.validsoft.com) were featured recently by Josh Levine in his MicroCap Investor newsletter. The report is available at: http://levinesmicrocapinvestor.com/news/2011/04-14-11.aspx
Visit the Cloud computing stocks directory at Investorideas.com
http://www.investorideas.com/TSS/Cloud_Computing_Stocks.asp
Cloud Computing Stock Snapshot:
GBS Enterprises, Inc. (OTCBB:GBSX) is the parent company of Group Business Software (GBS) which provides a portfolio of Cloud Computing software technologies and Application Services to address the needs of private enterprises, Data Center providers, ISV's, OEM's as well as government organizations. GBS caters primarily to mid-market and enterprise B2B size organizations. GBS has over 3,500 customers in thirty-eight countries spanning four continents, representing more than 5,000,000 active users of its product s.
Visit the GBSX company profile on Investorideas.com
Request news and info on GBSX
Company Contact:
Gary MacDonald
EVP and Chief Corporate Development Officer
GBS Enterprises, Incorporated
+1.917.477.9509
gmacdonald@gbsx.us
Sign up for the free investor news letter and get stock alerts in leading sectors!
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising .
Disclosure: GBS Enterprises, Inc. (OTCBB: GBSX) is a paid showcase tech stock, cloud computing stock on Investorideas.com (April 2011 - 1500 per month by third party)
Disclosure: Investorideas.com is a partner of Josh Levines Microcap. Investorideas.com is not long and is not compensated by ETAK.
www.InvestorIdeas.com/About/Disclaimer.asp
www.Investorideas.com
Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com
Source - Investorideas.com
Sector Snapshot
- Elephant Talk Communications Inc. (OTCBB: ETAK) trading at$2.69, down 0.01 (0.37%)
- GBS Enterprises, Inc. (OTCBB: GBSX) trading at $4.25
- Juniper Networks, Inc. (NYSE: JNPR ) trading up at $39.47, up 0.21 (0.53%) 10:12AM EDT
- Rackspace Hosting, Inc (NYSE: RAX) trading at$ 44.26, up 0.34 (0.77%)
- Salesforce.com Inc (NYSE: CRM ) trading at $139.25, down 2.83 (1.99%) 10:15AM EDT, trading as high as $141.98 in earlier trading
- VMware Inc. (NYSE: VMW ) trading at $95.69, down 2.21 (2.26%) 10:16AM EDT
http://www.investorideas.com/TSS/Cloud_Computing_Stocks.asp
Market Snapshot:
- Dow 12,459.07 +5.53 +0.04%
- Nasdaq 2,810.35 +7.84 +0.28%
- S&P 500 1,333.79 +3.43 +0.26%
- 10 Yr Bond(%) 3.38% -0.02
- Oil 111.26 -0.19 -0.17%
- Gold 1,501.70 +3.40 +0.23
VMware Reports First Quarter 2011 Results
- Year-over-Year Revenue Growth of 33% to $844 Million
- EPS Growth of 53% to $0.29; Non-GAAP EPS Growth of 50% to $0.48
- Operating Margin of 18.2%; Non-GAAP Operating Margin of 29.9%
- Trailing Twelve Months Operating Cash Flows Growth of 20% to $1.3 Billion; Free Cash Flows Growth of 39% to $1.3 Billion
- Revenues for the first quarter were $844 million, an increase of 33% from the first quarter of 2010.
- Operating income for the first quarter was $154 million, an increase of 50% from the first quarter of 2010. Non-GAAP operating income for the first quarter was $252 million, an increase of 44% from the first quarter of 2010.
- Net income for the first quarter was $126 million, or $0.29 per diluted share, compared to $78 million, or $0.19 per diluted share, for the first quarter of 2010. Non-GAAP net income for the quarter was $204 million, or $0.48 per diluted share, compared to $133 million, or $0.32 per diluted share, for the first quarter of 2010.
- Operating cash flows for the first quarter were $478 million, an increase of 35% from the first quarter of 2010. Free cash flows for the quarter were $473 million, an increase of 45% from the first quarter of 2010.
- Trailing twelve months operating cash flows were $1.3 billion, an increase of 20%. Trailing twelve months free cash flows were $1.3 billion, an increase of 39%.
- Cash, cash equivalents and short-term investments were $3.7 billion and unearned revenue was $2.0 billion as of March 31, 2011.
More: http://www.vmware.com/company/news/releases/vmw-earnings-q111.html
Elephant Talk and Its ValidSoft Subsidiary Featured in Josh Levine's MicroCap Investor Newsletter- Companies Positioned to Profit From "Securing the Mobile Cloud"
SCHIPHOL, THE NETHERLANDS--- Elephant Talk Communications Inc. (OTC.BB: ETAK - News) (http://www.elephanttalk.com) has announced that the company and its wholly-owned subsidiary, ValidSoft Limited, (www.validsoft.com) were featured recently by Josh Levine in his MicroCap Investor newsletter. The report is available at: http://levinesmicrocapinvestor.com/news/2011/04-14-11.aspx
Visit the Cloud computing stocks directory at Investorideas.com
http://www.investorideas.com/TSS/Cloud_Computing_Stocks.asp
Cloud Computing Stock Snapshot:
GBS Enterprises, Inc. (OTCBB:GBSX) is the parent company of Group Business Software (GBS) which provides a portfolio of Cloud Computing software technologies and Application Services to address the needs of private enterprises, Data Center providers, ISV's, OEM's as well as government organizations. GBS caters primarily to mid-market and enterprise B2B size organizations. GBS has over 3,500 customers in thirty-eight countries spanning four continents, representing more than 5,000,000 active users of its product s.
Visit the GBSX company profile on Investorideas.com
Request news and info on GBSX
Company Contact:
Gary MacDonald
EVP and Chief Corporate Development Officer
GBS Enterprises, Incorporated
+1.917.477.9509
gmacdonald@gbsx.us
Sign up for the free investor news letter and get stock alerts in leading sectors!
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising .
Disclosure: GBS Enterprises, Inc. (OTCBB: GBSX) is a paid showcase tech stock, cloud computing stock on Investorideas.com (April 2011 - 1500 per month by third party)
Disclosure: Investorideas.com is a partner of Josh Levines Microcap. Investorideas.com is not long and is not compensated by ETAK.
www.InvestorIdeas.com/About/Disclaimer.asp
www.Investorideas.com
Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com
Source - Investorideas.com
Biotech/Pharma Investor Spotlight; Profile for BioSante Pharmaceuticals (NASDAQ: BPAX) and its Lead Products, LibiGel® and Bio-T-Gel™
Point Roberts, WA - April 21, 2011 (Investorideas.com Newswire) Investorideas.com, a leader in sector stock research including biotech and pharma stocks, profiles BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) and its lead products, LibiGel® (testosterone gel) and Bio-T-Gel.
Hi-lights are featured within the research report, updated product brochure, recent news and a recent Q&A interview.
Recent Equity Research:
"Our $5 price target is derived by applying a 5x multiple to our base case projection for LibiGel sales of $422MM in 2016, discounted by 30% per year." JMP Securities
Read the full report:
http://www.investorideas.com/CO/BPAX/news/Initiating-Coverage-031611.pdf
Recent News for LibiGel Product:
Biotech/Pharma Stock News; BioSante Pharmaceuticals (NASDAQ: BPAX) Completes Enrollment in Both Pivotal LibiGel® Phase III Efficacy Trials
LINCOLNSHIRE , Ill. - March 30, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) today announced that enrollment of subjects in the second of two pivotal Phase III LibiGel (testosterone gel) safety and efficacy trials has been completed. Enrollment in the first LibiGel efficacy trial was completed in February. The efficacy trials are being conducted under an FDA-approved special protocol assessment (SPA) agreement. LibiGel is in development for the treatment of female sexual dysfunction (FSD), specifically, hypoactive sexual desire disorder (HSDD) in menopausal women, for which there is no FDA-approved product.
"This is an important achievement for BioSante and a key step toward completing the LibiGel Phase III clinical development program," said Joanne Zborowski, BioSante's vice president of clinical development. "There are more than 1,000 subjects in the efficacy trials and we anticipate announcing top-line efficacy data this fall. In addition, we have over 3,000 subjects enrolled in our LibiGel Phase III safety study," she added.
Read Full News at: http://www.investorideas.com/CO/BPAX/news/2011/03301.asp
Highlights from the LibiGel Brochure:
Read the Full Brochure at: http://www.biosantepharma.com/libigel/LibiGel-Brochure.pdf
Recent News for Bio-T-Gel: Bio-T-Gel NDA pending with PDUFA date of November 14, 2011. NDA filed by Teva
On April 13, 2011, BioSante announced that a New Drug Application (NDA) has been accepted for filing by the U.S. Food and Drug Administration (FDA) following submission in January 2011 by a subsidiary of Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA). The FDA has assigned a PDUFA date of November 14, 2011. The PDUFA date is the target date for the FDA to complete its review of the NDA.
Bio-T-Gel is a testosterone gel for the treatment of male hypogonadism or low testosterone levels. Bio-T-Gel was developed initially by BioSante, and then it was licensed to Teva for late stage clinical development. Teva is responsible for all Bio-T-Gel regulatory and marketing activities. BioSante will receive certain milestone payments and royalties upon commercialization. The current U.S. market for male testosterone products is over $1.2 billion .
LibiGel R & D Event
On April 7, 2011, BioSante hosted a review of female sexual dysfunction (FSD) and the safety of testosterone in women by independent experts, as well as an update of the LibiGel (testosterone gel) development program, for institutional investors and analysts in New York City. The full presentations and slides presented at the LibiGel R & D Event are available on BioSante’s website at www.biosantepharma.com
Interview
Full interview with Mr. Simes can be read here: http://www.investorideas.com/CO/BPAX/news/2011/03281.asp
About BioSante Pharmaceuticals, Inc.
BioSante (NASDAQ: BPAX) is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante’s lead products include LibiGel ® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante’s first FDA-approved product is Elestrin™ (estradiol gel) indicated for the treatment of hot flashes associated with menopause, marketed in the U.S. by Azur Pharma, BioSante’s licensee. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other products are Bio-T-Gel™, a testosterone gel for male hypogonadism, for which an NDA is pending with a PDUFA date of November 14, 2011, licensed to Teva Pharmaceuticals, and an oral contraceptive in Phase II clinical development using BioSante patented technology. Additional information is available online at: www.biosantepharma.com.
This news release may contain forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include statements about BioSante’s plans, objectives, expectations and intentions with respect to future operations and products, future market acceptance, size and potential of LibiGel and other statements identified by words such as "will,” "potential,” "could,” "would,” "can,” "believe,” "intends,” "continue,” "plans,” "expects,” "anticipates,” "estimates,” "may,” other words of similar meaning or the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante’s actual results to be materially different than those expressed in or implied by BioSante’s forward-looking statements. For BioSante, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing success of BioSante’s licensees or sublicensees; the success of clinical testing; and BioSante’s need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect BioSante’s actual results are described in BioSante’s filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. All forward-looking statements in this presentation speak only as of the date of this presentation. BioSante undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Contact BioSante:
For Investors:
The Trout Group LLC
> Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
or
For Media:
McKinney/Chicago
Alan Zachary
(312) 944-6784 ext. 316
azachary@mckinneychicago.com
The full BPAX company profile is available at Investorideas.com
http://www.investorideas.com/CO/BPAX/
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com :
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Sign up for the free investor news letter and get stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer: The following news/content is paid for as part of the BPAX showcase program (one thousand per month) Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Source: Investorideas.com, BioSante, Investorideas.com
Contact Investorideas.com 800 665 0411 cvanzant@investorideas.com
Point Roberts, WA - April 21, 2011 (Investorideas.com Newswire) Investorideas.com, a leader in sector stock research including biotech and pharma stocks, profiles BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) and its lead products, LibiGel® (testosterone gel) and Bio-T-Gel.
Hi-lights are featured within the research report, updated product brochure, recent news and a recent Q&A interview.
Recent Equity Research:
"Our $5 price target is derived by applying a 5x multiple to our base case projection for LibiGel sales of $422MM in 2016, discounted by 30% per year." JMP Securities
Read the full report:
http://www.investorideas.com/CO/BPAX/news/Initiating-Coverage-031611.pdf
Recent News for LibiGel Product:
Biotech/Pharma Stock News; BioSante Pharmaceuticals (NASDAQ: BPAX) Completes Enrollment in Both Pivotal LibiGel® Phase III Efficacy Trials
LINCOLNSHIRE , Ill. - March 30, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) today announced that enrollment of subjects in the second of two pivotal Phase III LibiGel (testosterone gel) safety and efficacy trials has been completed. Enrollment in the first LibiGel efficacy trial was completed in February. The efficacy trials are being conducted under an FDA-approved special protocol assessment (SPA) agreement. LibiGel is in development for the treatment of female sexual dysfunction (FSD), specifically, hypoactive sexual desire disorder (HSDD) in menopausal women, for which there is no FDA-approved product.
"This is an important achievement for BioSante and a key step toward completing the LibiGel Phase III clinical development program," said Joanne Zborowski, BioSante's vice president of clinical development. "There are more than 1,000 subjects in the efficacy trials and we anticipate announcing top-line efficacy data this fall. In addition, we have over 3,000 subjects enrolled in our LibiGel Phase III safety study," she added.
Read Full News at: http://www.investorideas.com/CO/BPAX/news/2011/03301.asp
Highlights from the LibiGel Brochure:
Read the Full Brochure at: http://www.biosantepharma.com/libigel/LibiGel-Brochure.pdf
Recent News for Bio-T-Gel: Bio-T-Gel NDA pending with PDUFA date of November 14, 2011. NDA filed by Teva
On April 13, 2011, BioSante announced that a New Drug Application (NDA) has been accepted for filing by the U.S. Food and Drug Administration (FDA) following submission in January 2011 by a subsidiary of Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA). The FDA has assigned a PDUFA date of November 14, 2011. The PDUFA date is the target date for the FDA to complete its review of the NDA.
Bio-T-Gel is a testosterone gel for the treatment of male hypogonadism or low testosterone levels. Bio-T-Gel was developed initially by BioSante, and then it was licensed to Teva for late stage clinical development. Teva is responsible for all Bio-T-Gel regulatory and marketing activities. BioSante will receive certain milestone payments and royalties upon commercialization. The current U.S. market for male testosterone products is over $1.2 billion .
LibiGel R & D Event
On April 7, 2011, BioSante hosted a review of female sexual dysfunction (FSD) and the safety of testosterone in women by independent experts, as well as an update of the LibiGel (testosterone gel) development program, for institutional investors and analysts in New York City. The full presentations and slides presented at the LibiGel R & D Event are available on BioSante’s website at www.biosantepharma.com
Interview
Full interview with Mr. Simes can be read here: http://www.investorideas.com/CO/BPAX/news/2011/03281.asp
About BioSante Pharmaceuticals, Inc.
BioSante (NASDAQ: BPAX) is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante’s lead products include LibiGel ® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante’s first FDA-approved product is Elestrin™ (estradiol gel) indicated for the treatment of hot flashes associated with menopause, marketed in the U.S. by Azur Pharma, BioSante’s licensee. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other products are Bio-T-Gel™, a testosterone gel for male hypogonadism, for which an NDA is pending with a PDUFA date of November 14, 2011, licensed to Teva Pharmaceuticals, and an oral contraceptive in Phase II clinical development using BioSante patented technology. Additional information is available online at: www.biosantepharma.com.
This news release may contain forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include statements about BioSante’s plans, objectives, expectations and intentions with respect to future operations and products, future market acceptance, size and potential of LibiGel and other statements identified by words such as "will,” "potential,” "could,” "would,” "can,” "believe,” "intends,” "continue,” "plans,” "expects,” "anticipates,” "estimates,” "may,” other words of similar meaning or the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante’s actual results to be materially different than those expressed in or implied by BioSante’s forward-looking statements. For BioSante, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing success of BioSante’s licensees or sublicensees; the success of clinical testing; and BioSante’s need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect BioSante’s actual results are described in BioSante’s filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. All forward-looking statements in this presentation speak only as of the date of this presentation. BioSante undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Contact BioSante:
For Investors:
The Trout Group LLC
> Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
or
For Media:
McKinney/Chicago
Alan Zachary
(312) 944-6784 ext. 316
azachary@mckinneychicago.com
The full BPAX company profile is available at Investorideas.com
http://www.investorideas.com/CO/BPAX/
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com :
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Sign up for the free investor news letter and get stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer: The following news/content is paid for as part of the BPAX showcase program (one thousand per month) Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Source: Investorideas.com, BioSante, Investorideas.com
Contact Investorideas.com 800 665 0411 cvanzant@investorideas.com
Security Stocks; UPSG (TSX-V: UZZ) MOVES INTO EASTERN CANADA
EDMONTON - April 20, 2011 (InvestorIdeas.com Newswire) - F.V.Ramsoondar, Chief Executive Officer of United Protection Security Group Inc. (UPSG or the Company), (TSX-V:UZZ) announces the appointment of Don Dassanayake as Senior Vice President of Operations and Business Development for Eastern Canada.
Mr. Ramsoondar further states: "Don's appointment is the first step in a national growth strategy that will be deployed in 2011 and beyond. Our objective is to grow the Company into one of the largest national security service providers in Canada over the next five years."
Don was the Chief Financial Officer of the Canadian division of the world's largest security company. He was also a senior member of the executive management and acquisition teams and contributed to the company growing its Canadian operations from $23 million to $200 million in annual revenues. During his tenure he was involved with closing several successful acquisitions.
Don Dassanayake joins UPSG with over 20 years experience in the security industry. He is a member of the Chartered Institute of Management Accountants and past member of the Institute of Data Processing Management in the United Kingdom.
Don's mandate is to build UPSG's Eastern Canada operations through acquisitions and future organic growth.
Stock Awareness Activities
To find out more about United Protection Security Group Inc. (TSX-V:UZZ), visit our website at www.unitedprotection.com. To join the 'request for information', go to the web page www.unitedprotection.com and click the tab 'request information' and follow the prompts. You may also email Investor Relations at: iruzz@unitedprotection.com.
Statements in this press release other than purely historical information, including statements relating to the Company's future plans and objectives or expected results, are forward-looking statements. Forward-looking statements are based on numerous assumptions and are subject to all of the risks and uncertainties inherent in the Company's business, including risks related to business development and retention, and risks related to the current economic and credit conditions. As a result, actual results may vary materially from those described in the forward-looking statements.
The TSX Venture Exchange has neither approved nor disapproved the information contained herein.
Disclosure: UZZ is a paid advertising client on Investorideas.com and our defense portals.
EDMONTON - April 20, 2011 (InvestorIdeas.com Newswire) - F.V.Ramsoondar, Chief Executive Officer of United Protection Security Group Inc. (UPSG or the Company), (TSX-V:UZZ) announces the appointment of Don Dassanayake as Senior Vice President of Operations and Business Development for Eastern Canada.
Mr. Ramsoondar further states: "Don's appointment is the first step in a national growth strategy that will be deployed in 2011 and beyond. Our objective is to grow the Company into one of the largest national security service providers in Canada over the next five years."
Don was the Chief Financial Officer of the Canadian division of the world's largest security company. He was also a senior member of the executive management and acquisition teams and contributed to the company growing its Canadian operations from $23 million to $200 million in annual revenues. During his tenure he was involved with closing several successful acquisitions.
Don Dassanayake joins UPSG with over 20 years experience in the security industry. He is a member of the Chartered Institute of Management Accountants and past member of the Institute of Data Processing Management in the United Kingdom.
Don's mandate is to build UPSG's Eastern Canada operations through acquisitions and future organic growth.
Stock Awareness Activities
To find out more about United Protection Security Group Inc. (TSX-V:UZZ), visit our website at www.unitedprotection.com. To join the 'request for information', go to the web page www.unitedprotection.com and click the tab 'request information' and follow the prompts. You may also email Investor Relations at: iruzz@unitedprotection.com.
Statements in this press release other than purely historical information, including statements relating to the Company's future plans and objectives or expected results, are forward-looking statements. Forward-looking statements are based on numerous assumptions and are subject to all of the risks and uncertainties inherent in the Company's business, including risks related to business development and retention, and risks related to the current economic and credit conditions. As a result, actual results may vary materially from those described in the forward-looking statements.
The TSX Venture Exchange has neither approved nor disapproved the information contained herein.
Disclosure: UZZ is a paid advertising client on Investorideas.com and our defense portals.
Published at the Investor Ideas Newswire
Subscribe to:
Posts (Atom)